Invesaro

Stocks Consumer discretionary HAO

NASDAQ · Consumer discretionary

Haoxi Health Technology Ltd (HAO)

Haoxi Health Technology Ltd reported revenue of $54.8M in fiscal 2026, up 67.1% from a year earlier. It posted a net loss of $9.5M. At June 30, 2026 it held $10.9M in cash against $290.7K of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on September 30, 2026.

Free, no password. An email when HAO files with the SEC.

Price
$1.86
-3.89% on the day · November 11, 2026
52-week range $1.60 to $4,352.00
Market cap
$679.2K
Revenue (FY2026)
$54.8M
+67.1% year on year
Net margin
-17.4%

Key facts about Haoxi Health Technology Ltd

Net worth
Haoxi Health Technology Ltd has a market value (market cap) of $679.2K at the latest share price, and shareholders' equity of $17.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $54.8M (+67.1% year on year), with a net loss of $9.5M.
Cash flow
In fiscal 2026 operations used $2.6M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on September 30, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Haoxi Health Technology Ltd's next report is expected around September 16, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Haoxi Health Technology Ltd does

Haoxi Health Technology Ltd is registered with the SEC under industry code SIC 7311 (Services-Advertising Agencies). Its shares trade on NASDAQ under the ticker HAO.

Revenue and profit by year

Revenue
FY22: $16.2M $16.2M FY22FY24: $28.2M $28.2M FY24FY24: $48.5M $48.5M FY24FY25: $32.8M $32.8M FY25FY26: $54.8M $54.8M FY26
Net income
FY22: $244.6K $244.6K FY22FY24: $969.8K $969.8K FY24FY24: $1.3M $1.3M FY24FY25: $3.9M $3.9M FY25FY26: -$9.5M -$9.5M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$54.8M-$9.7M-$9.5M-$386.40n/a
2025$32.8M-$2M$3.9M$3,385.53n/a
2024$48.5M$1.7M$1.3M$2,701.53-$802.9K
2024$28.2M$1.2M$969.8K$2,217.29-$917.6K
2022$16.2M$268.8K$244.6K$554.32-$684.1K

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around September 16, 2027.

Estimated from its filing rhythm: about 351 days after its last report of September 30, 2026, its usual gap. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where HAO ranks in Consumer discretionary

Revenue$54.8M
#805 of 1077 in Consumer discretionary · Bottom 25%
Revenue growth+67.1%
#37 of 952 in Consumer discretionary · Top 4%
Net margin-17.4%
#849 of 968 in Consumer discretionary · Bottom 12%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Haoxi Health Technology Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 30, 2026
    Annual report (foreign issuer)20-F · period to June 30, 2026Haoxi Health Technology reported strong revenue growth for fiscal 2026 but swung to a net loss amid rising operating expenses and heavy supplier concentration.Revenue rose 67% to $54.8M versus the prior year; diluted EPS -$386.40 versus $3,385.53.
  2. July 13, 2026
  3. July 6, 2026
  4. June 24, 2026
  5. June 4, 2026
  6. May 21, 2026
  7. May 19, 2026
  8. May 13, 2026
  9. April 22, 2026
  10. April 6, 2026

Recent insider filings (Forms 3, 4 and 144): 7, the latest on May 20, 2026. Insider transactions on SEC

Insider trades

What the people running Haoxi Health Technology Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
May 19, 2026 Fan ZhenCEO & Chairman, Director, 10% owner Bought 40,000,000 $0.02 $720K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HAO

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Meteora Capital, LLC13G, passive with 1 related filers 9.01% 68,372 May 15, 2025

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 40,690,800 shares in total, about $75.5M at the last price.

HolderSharesAs of
Fan ZhenCEO & Chairman, Director, 10% owner 40,690,800 May 19, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HAO

What does Haoxi Health Technology Ltd do?

Haoxi Health Technology Ltd is a company in the Consumer discretionary sector, listed on NASDAQ as HAO. Its shares trade on NASDAQ under the ticker HAO.

What is Haoxi Health Technology Ltd's net worth?

Haoxi Health Technology Ltd has a market value (market cap) of $679.2K at the latest share price, and shareholders' equity of $17.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Haoxi Health Technology Ltd profitable?

No. In fiscal 2026 it reported a net loss of $9.5M on revenue of $54.8M.

How much revenue does Haoxi Health Technology Ltd make?

In fiscal 2026 Haoxi Health Technology Ltd reported revenue of $54.8M. That is 67.1% more than a year earlier.

When did Haoxi Health Technology Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on September 30, 2026. It covers the period to June 30, 2026.

When is Haoxi Health Technology Ltd's next earnings report?

Haoxi Health Technology Ltd's next report is expected around September 16, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare HAO with

Compare HAO with any company

Follow HAO

Get an email when Haoxi Health Technology Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when HAO files with the SEC.

Where the numbers come from

Financial figures are the values Haoxi Health Technology Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.